Skip to content

Press Release Details

Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2024 Results: November 2, 2023

Oct 5, 2023

BOSTON, Oct. 5, 2023 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish second quarter fiscal year 2024 financial results at 6:00 am ET on Thursday, November 2, 2023. The Company will hold a conference call with investors and analysts to discuss results and answer questions at 8:00 am ET on November 2, 2023.

The call can be accessed via teleconference at: Q2 2024 Haemonetics Corporation Earnings Conference Call. Once registration is completed, participants will receive a dial-in number along with a personalized PIN to access the call. While not required, it is recommended that participants join 10 minutes prior to the event start.

A live webcast of the call can be accessed on Haemonetics' investor relations website. Webcast Link: 

A replay of the conference call and webcast will be available for one year beginning on November 2, 2023 at 11:00 am ET using the conference call webcast link provided in this press release.

About Haemonetics

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit

Investor Contacts:                                                       

Olga Guyette, Sr. Director-Investor Relations & Treasury

David Trenk, Manager-Investor Relations

(781) 356-9763                                                                 

(203) 733-4987                                                                                                           

Media Contact:                                                                   

Josh Gitelson, Director-Global Communications     

(781) 356-9776                                                                                                    

Cision View original content to download multimedia:

SOURCE Haemonetics Corporation